![W. Hertz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
W. Hertz
Verkställande Direktör på
GRI BIO, INC.
Förmögenhet: 11 $ per 2026-07-31
Profil
Dr. W.
M.
Hertz is a President, Chief Executive Officer & Director at GRI Bio, Inc., a President, Chief Executive Officer & Director at GRI Bio Operations, Inc. and a Chairman at Multimeric Biotherapeutics, Inc. He is on the Board of Directors at GRI Bio, Inc. and GRI Bio Operations, Inc. Dr. Hertz was previously employed as a Chief Executive Officer & Director by Vallon Pharmaceuticals, Inc., a Chairman by Evozym Biologics, Inc., and a Chief Executive Officer by Pharmexa, Inc. (New York).
He also served on the board at Gemvax AS.
He received his undergraduate degree from Bowdoin College and a doctorate degree from CU Anschutz Medical Campus.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-17 | 8 ( 0 % ) | 11 $ | 2026-07-31 |
Aktiva positioner av W. Hertz
| Företag | Position | Start |
|---|---|---|
| GRI BIO, INC. | Verkställande Direktör | 2023-04-01 |
Multimeric Biotherapeutics, Inc.
 Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a early-stage biotech company | Grundare | 1998-01-01 |
GRI Bio Operations, Inc.
 GRI Bio Operations, Inc. BiotechnologyHealth Technology Operates as a bio-technology company which develops cell based therapies for inflammatory diseases | Grundare | 2009-01-01 |
Tidigare kända positioner av W. Hertz
| Företag | Position | Slut |
|---|---|---|
Evozym Biologics, Inc.
 Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins | Ordförande | 2018-01-01 |
Gemvax AS
 Gemvax AS Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Direktör/Styrelseledamot | 2009-01-01 |
Pharmexa, Inc. (New York) | Verkställande Direktör | 2008-08-01 |
| GRI BIOPAR | Verkställande Direktör | - |
W. Hertzs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Evozym Biologics, Inc.
Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins | Commercial Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Pharmexa, Inc. (New York) | |
Multimeric Biotherapeutics, Inc.
Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a early-stage biotech company | Health Technology |
GRI Bio Operations, Inc.
GRI Bio Operations, Inc. BiotechnologyHealth Technology Operates as a bio-technology company which develops cell based therapies for inflammatory diseases | Health Technology |
CU Anschutz Medical Campus
 CU Anschutz Medical Campus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
